spot on 4 dollars- it is a massive claim- and that claim is not in any way shape or form supported by their analysis. In fact the more you look at this so-called " naïve" comparison the more flawed it looks- good grief they're even comparing with ancient studies from the early 1980's. In fact there is just so much scope for bias (in favour of panco) in this type of analysis given all the different (out-dated) chemos etc (I've shown this to a biostatistician and he agrees) to make it worthless. Then again, I'm not the regulator and decision-maker but I'd be very surprised if BSI-COC bought all this and think it's valid.
Unfortunately I was unable to attend the AGM. How was their presentation received? Had they received feedback from COC as promised? And any further insights provided into the departures of the CMO and CFO within a week of each other, just before their London meeting?
OSL Price at posting:
12.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)